Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed safety, pharmacokinetics and pharmacodynamics of 2B3-201 in healthy volunteers and multiple sclerosis patients and the study has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• 2B3-201 (2B3-201)

Snippet

Sponsor: BBB-Therapeutics B.V. | Conditions: Healthy Volunteers, Multiple Sclerosis | Phase 1 | Status: TERMINATED